Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.110
-0.120 (-2.84%)
At close: Apr 17, 2026, 4:00 PM EDT
4.058
-0.052 (-1.27%)
After-hours: Apr 17, 2026, 7:41 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $193.98 million as of April 17, 2026. Its market cap has increased by 143.89% in one year.
Market Cap
193.98M
Enterprise Value
48.28M
1-Year Change
143.89%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $193.98M, a decrease of -64.13%. That is a compound annual growth rate of -19.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 193.98M | 70.08% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 195.19M |
| Enlivex | 194.65M |
| Karyopharm Therapeutics | 192.97M |
| Protalix BioTherapeutics | 191.76M |
| Achieve Life Sciences | 189.00M |
| Replimune Group | 188.27M |
| Agenus | 185.46M |
| Heron Therapeutics | 180.37M |